.Attributes Medicine, Released online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- drug conjugate (ADC) tisotumab vedotin resulted in improved progression-free and also total survival, causing FDA commendation as well as a brand-new treatment possibility for individuals.